FY26 UDO initiative - reagents for microbiome research experiments (r) 10X genomics, INC.:1279204 [25-009814]
Ended Purchase Order Awarded
- Contract number
- 75N90025P00731
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,299
Award facts
- Contract value 100% obligated
- $12,298.50 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a $12,298.50 firm fixed price purchase order to 10X Genomics, Inc. on September 17, 2025, for reagents supporting microbiome research experiments under the FY26 Unmet Data Opportunity (UDO) Initiative. The contract, which carries no set-aside designation, is scheduled for completion by October 18, 2025, with performance at 10X Genomics' headquarters in Pleasanton, California. This purchase order represents a direct procurement of specialized genomic analysis consumables essential to the NIH Clinical Center's research operations.
10X Genomics is a leading biotechnology company specializing in single-cell and spatial transcriptomics platforms and associated reagents. The company has maintained an extensive contracting relationship with the NIH system since 2015, including substantial indefinite delivery contracts with the National Institute on Aging ($7 million through July 2029) and the National Institute of Neurological Disorders and Stroke ($750,000), which generate regular task orders for similar genomic research consumables. This UDO Initiative purchase order aligns with 10X Genomics' established role as a primary federal supplier of advanced molecular research tools critical to NIH-supported biomedical research.
Quick answers
Who was awarded contract 75N90025P00731?
75N90025P00731 was awarded to 10X Genomics, Inc. by NIH Clinical Center (National Institutes of Health) on September 17, 2025.
How much is contract 75N90025P00731 worth?
The government has obligated $12,299 on 75N90025P00731.
Was contract 75N90025P00731 competed?
The extent of competition for 75N90025P00731 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award